✦ LIBER ✦

Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease

✍ Scribed by Kevin Mills; Ashok Vellodi; Peter Morris; Donald Cooper; Michael Morris; Elisabeth Young; Bryan Winchester

Publisher: Springer
Year: 2004
Tongue: English
Weight: 333 KB
Volume: 163
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00431-004-1484-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vestibular and auditory deficits in Fabr

Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy

✍ A. Palla; S. Hegemann; U. Widmer; D. Straumann 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 311 KB

Focal splenic lesions in type I Gaucher

Focal splenic lesions in type I Gaucher disease are associated with poor platelet and splenic response to macrophage-targeted enzyme replacement therapy

✍ Philip Stein; Advitya Malhotra; Andrew Haims; Gregory M. Pastores; Pramod K. Mis 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 179 KB

Hyperargininemia: The rat as a model for

Hyperargininemia: The rat as a model for the human disease and the comparative response to enzyme replacement therapy with free arginase and arginase-loaded erythrocytes in vivo

✍ K. Adriaenssens; D. Karcher; B. Marescau; Chr. Van Broeckhoven; A. Lowenthal; H. 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 667 KB

A novel mutation of the GAA gene in a Fi

A novel mutation of the GAA gene in a Finnish late-onset pompe disease patient: Clinical phenotype and follow-up with enzyme replacement therapy

✍ Mari P. Korpela; Anders Paetau; Mervi I. Löfberg; Marjut H. Timonen; Antti E. La 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

## Abstract Pompe disease is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α‐glucosidase (GAA) enzyme. Herein we report the first diagnosed Finnish patient with a phenotype compatible with the late‐onset form of Pompe disease. Molecular genetic analys

Letter concerning “Enzyme replacement th

Letter concerning “Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha”, by Tanaka et al.

✍ Gabor E. Linthorst; Johannes M. F. G. Aerts 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 63 KB